Legend Biotech (LEGN) Income towards Parent Company: 2019-2025
Historic Income towards Parent Company for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -$38.5 million.
- Legend Biotech's Income towards Parent Company fell 157.58% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.7 million, marking a year-over-year decrease of 130.38%. This contributed to the annual value of -$177.0 million for FY2024, which is 65.84% up from last year.
- Per Legend Biotech's latest filing, its Income towards Parent Company stood at -$38.5 million for Q3 2025, which was up 69.04% from -$124.2 million recorded in Q2 2025.
- Legend Biotech's Income towards Parent Company's 5-year high stood at $257.8 million during Q2 2022, with a 5-year trough of -$135.9 million in Q4 2022.
- In the last 3 years, Legend Biotech's Income towards Parent Company had a median value of $66.8 million in 2024 and averaged $48.1 million.
- Per our database at Business Quant, Legend Biotech's Income towards Parent Company crashed by 35,570.18% in 2022 and then surged by 447.18% in 2023.
- Legend Biotech's Income towards Parent Company (Quarterly) stood at -$88.3 million in 2021, then slumped by 53.82% to -$135.9 million in 2022, then soared by 99.89% to -$144,818 in 2023, then skyrocketed by 118.15% to $26,284 in 2024, then plummeted by 157.58% to -$38.5 million in 2025.
- Its last three reported values are -$38.5 million in Q3 2025, -$124.2 million for Q2 2025, and $100.9 million during Q1 2025.